Radiotherapy Improves Survival in Non-Small Cell Lung Cancer Following Oligoprogression on Immunotherapy: A Cohort Study

被引：0
|
作者：
Brown, L. J. [1 ,2 ,3 ,4 ]
Ahn, J. [1 ]
Gao, B. [1 ,2 ,3 ]
Gee, H. [1 ,4 ,5 ]
Nagrial, A. [1 ,2 ,3 ]
Da Silva, I. E. D. P. [2 ,3 ,6 ]
Hau, E. [1 ,2 ,3 ,4 ]
机构：
[1] Westmead Hosp, Westmead, NSW, Australia
[2] Blacktown Hosp, Blacktown, NSW, Australia
[3] Univ Sydney, Camperdown, NSW, Australia
[4] Westmead Inst Med Res, Westmead, NSW, Australia
[5] Childrens Med Res Inst, Westmead, NSW, Australia
[6] Melanoma Inst Australia, Wollstonecraft, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
oligoprogression; immunotherapy; radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA05.04
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] A Response Letter to Kosaka et al. Regarding Manuscript Titled: "Radiotherapy Improves Survival in Non-Small Cell Lung Cancer Following Oligoprogression on Immunotherapy: A Cohort Study"
    Brown, Lauren Julia
    Ahn, Julie
    Gao, Bo
    Gee, Harriet
    Nagrial, Adnan
    Silva, Ines Pires da
    Hau, Eric
    JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (02):
  • [2] Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study
    Brown, Lauren Julia
    Ahn, Julie
    Gao, Bo
    Gee, Harriet
    Nagrial, Adnan
    Silva, Ines Pires da
    Hau, Eric
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (10):
  • [3] Radiotherapy for oligoprogression in metastatic non-small cell lung cancer patients receiving (chemo-)immunotherapy
    Deng, M.
    Bozorgmehr, F.
    Weykamp, F.
    Lang, K.
    Regnery, S.
    Held, T.
    Weusthof, K.
    Bauer, L.
    Waldsperger, H.
    Shafie, R. E.
    Rieken, S.
    Christopoulos, P.
    Thomas, M.
    Debus, J. Peter
    Adeberg, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S105 - S105
  • [4] Oligoprogression in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    CANCERS, 2021, 13 (22)
  • [5] Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer
    Gage, Anais
    Pereira, Bruno
    Belliere, Aurelie
    Janicot, Henri
    Jeannin, Gaelle
    Bourrachot, Clara
    Durand, Muriel
    Rolland-Debord, Camille
    Merle, Patrick
    BULLETIN DU CANCER, 2023, 110 (12) : 1234 - 1243
  • [6] Letter Regarding "Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study"
    Kosaka, Nanami
    Kataoka, Yuki
    JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (01):
  • [7] Immunotherapy Drug Improves Survival of Patients With Squamous Non-Small Cell Lung Cancer
    不详
    CANCER, 2015, 121 (20) : 3562 - 3563
  • [8] Immunotherapy Combined with Stereotactic Radiotherapy Improves Intracranial Control for Non-Small Cell Lung Cancer
    Enright, T.
    Witt, J. S.
    Burr, A.
    Yadav, P.
    Leal, T. A.
    Baschnagel, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E97 - E97
  • [9] Management of oligoprogression in non-small cell lung cancer patients
    Tartarone, Alfredo
    Lerose, Rosa
    Tartarone, Marina
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [10] Management of oligoprogression in non-small cell lung cancer patients
    Alfredo Tartarone
    Rosa Lerose
    Marina Tartarone
    Medical Oncology, 2022, 39
12345